INTRODUCTION
The central role of interleukin-7 (IL-7) in maintaining T cell homeostasis is well established. However, the mechanisms that regulate the homeostasis of IL-7 are more enigmatic. Early studies indicated that IL-7 is produced independently of external stimuli and by stromal cells, but not by cells of the hematopoietic lineage (Namen et al., 1988; Sakata et al., 1990; Whitlock and Witte, 1982) . These and other observations led to a widely accepted hypothesis that IL-7 is produced constitutively by lymphoid stroma and that equilibrium concentrations are maintained through continuous consumption by cells expressing IL-7 receptor (IL-7R) (Fry and Mackall, 2005; Mazzucchelli and Durum, 2007) . Since its proposal, this consumption model of IL-7 homeostasis has received indirect support (Hodge et al., 2011; Read et al., 2006; Sasson et al., 2006) , but it remains to be tested directly in vivo. Moreover, reports of inducible IL-7 expression have led to alternative models of IL-7 homeostasis (Guimond et al., 2009; Lundströ m et al., 2012; Sawa et al., 2009; Shalapour et al., 2010) .
Recent efforts to study IL-7 regulation have focused on using genetic approaches to identify the cellular sources of IL-7. Analysis of seven different IL-7 reporter mouse strains has revealed many sites of active Il7 transcription and instances of its regulation by inflammatory signals (Alves et al., 2009; Hara et al., 2012; Mazzucchelli et al., 2009; Miller et al., 2013; Onder et al., 2012; Repass et al., 2009; Shalapour et al., 2010) . Interestingly, these reporter models suggest that the lymph nodes (LNs), which are crucial for T cell homeostasis, are not the major sites of IL-7 production . The observation of a very low amount of IL-7 in LNs under basal conditions indicates that a complete study of IL-7 homeostasis in the T cell niche will require alternative strategies. Because T cells efficiently migrate to the T cell zones and proliferate in response to excess IL-7, we demonstrate that the availability of IL-7 in the T cell niche can be assessed via measurement of the proliferation of adoptively transferred T cells.
For the current study, we utilized the IL-7R-deficient mouse as a model of deregulated IL-7 homeostasis, given that its highly elevated basal IL-7 levels facilitate the detection of IL-7 availability in vivo. We report that radioresistant and not hematopoietic cells produce the IL-7 relevant to mature T cells. Our results also provide evidence to support a consumption model of IL-7 homeostasis and indicate that innate lymphoid cells (ILCs) are significant competitors for IL-7 within the T cell niche.
RESULTS

Il7r
-/-Mice Display Increased Availability of IL-7
We and others have previously reported that C57BL/6 (B6) mouse T cells adoptively transferred into non-irradiated syngeneic IL-7Ra chain (CD127)-deficient (Il7r À/À ) hosts undergo greater homeostatic proliferation than they do in control irradiated B6 (irr-B6) hosts ( Figure 1A ; Guimond et al., 2009; Martin et al., 2010; Osborne et al., 2011; Schluns et al., 2000) . The trend was observed for both naive CD4 + and naive CD8 + T cells, irrespective of whether they were polyclonal or monoclonal T cell antigen receptor (TCR) transgenic T cells ( Figure 1A ). This finding applied to even OT-II and SMARTA TCR transgenic lines that do not proliferate well in irr-B6 hosts, presumably as a result of low TCR avidity for self-peptide-major histocompatibility complex (MHC) ligands. Hence, conditions in Il7r À/À hosts can overcome the TCR affinity requirements for homeostatic proliferation.
Relative to irr-B6 mice, Il7r À/À mice possessed greater numbers of CD8 + and similar numbers of CD4 + host T cells (Figure 1B) , implying that the rates of donor T cell homeostatic proliferation did not correlate with the degree of host lymphopenia. Moreover, there was an inverse correlation between IL-7R expression on donor T cells and their rate of expansion in a given host (Figures 1A and 1C) . Given that IL-7R expression on T cells is downregulated in response to signals from IL-7 (Park et al., 2004) , these findings suggest that Il7r À/À mice possess more available IL-7 than irr-B6 mice. Two separate approaches ascertained that IL-7 was driving the enhanced rate of homeostatic proliferation of donor T cells in Il7r À/À hosts. First, hosts were injected with a blocking anti-IL-7R monoclonal antibody (mAb), clone A7R34, which led to a severe reduction or abrogation of donor T cell proliferation (Figure 1A) . Second, Il7r
Il7
À/À mice were generated, and when used as hosts, they also failed to support efficient proliferation of donor T cells ( Figure 1A ). Indeed, both approaches yielded similar results. These data confirm and extend a previous report (Guimond et al., 2009 ) that donor T cell homeostatic proliferation in Il7r À/À hosts is largely driven by elevated availability of cally provide a sensitive readout for IL-7 availability in the T cell niche. Hence, we used this technique as our main method to detect IL-7 in mouse tissues; we also used quantitative PCR to detect Il7 transcripts, but we didn't use immunohistochemistry, given that we and others have found it to be unreliable (data not shown; Mazzucchelli et al., 2009 ).
IL-7 Is Produced by Radioresistant Rather Than Hematopoietic Cells in Il7r
-/-Mice A preponderance of evidence supports the notion that stromal cells are the most important source of IL-7 in the LNs during homeostasis. However, it has been suggested that hematopoietic lineage cells are also a significant source of IL-7 (Guimond et al., 2009) . To determine the cellular fraction that produces IL-7 in Il7r À/À mice, we generated bone marrow (BM) chimeras with discrete IL-7 expression in either stromal or BM-derived cells. We assembled IL-7R-deficient mice expressing IL-7 only in the stromal compartment by reconstituting lethally irradiated Il7r À/À recipients with Il7r
In parallel, we generated the reciprocal chimeras with IL-7 expression limited to the BMderived cells (i.e., Il7r
), as well as control IL-7-sufficient (i.e., Il7r À/À BM / Il7r À/À ) and -deficient (i.e.,
Il7 transcripts were readily detected in the LNs of all BM chimeras with Il7 +/+ stroma and only weakly in those with Il7 Figure 2A ). To determine the amount of IL-7 that was available in the T cell niche of these mice, we monitored the homeostatic proliferation of adoptively transferred T cells. As observed for intact Il7r À/À hosts, Il7r À/À BM / Il7r À/À chimeras supported strong proliferation of adoptively transferred SMARTA CD4 + or P14 CD8 + T cells, and this proliferation was decreased in mice treated with A7R34 or in fully IL-7-deficient hosts, implicating IL-7 as the crucial mitogen ( Figure 2B ). The extent of donor cell proliferation was consistent between individual hosts within each group, and this is reflected in their division index scores (i.e., the average number of cellular divisions in the population) ( Figure 2C ; Roederer, 2011) . The greater rates of proliferation also correlated with increased recovery of donor T cells from host LNs and spleen ( Figure 2D ).
Unexpectedly, a substantial amount of donor P14 CD8 + T cell proliferation occurred independently of IL-7 (i.e., in hosts that were Il7 deficient and/or treated with A7R34) (Figures 2B and  2C ; data not shown). Relative to CD4 + T cells, CD8 + T cells are more sensitive to IL-15, which might contribute to the P14 cell response in these experiments. Indeed, donor CD8 + T cell prolif- 
IL-7R Expressed by Hematopoietic Cells Controls IL-7 Availability
The above data demonstrate that stromal-cell-derived IL-7 is abundant in the T cell niche of Il7r À/À mice. We next sought to understand the role that IL-7R plays in regulating the availability of IL-7. Several studies support the hypothesis that IL-7R + hematopoietic cells regulate IL-7 levels in vivo (Henriques et al., 2010; Hodge et al., 2011; Park et al., 2004) . More recently, however, it was proposed that IL-7R expressed on stromal cells might also influence IL-7 availability (Lundströ m et al., 2012 Figures S2A-S2F ). These data suggest that the IL-7 disequilibrium observed in Il7r À/À mice was due to the specific absence of IL-7R + BM-derived cells and indicate that the hematopoietic compartment, and not the stroma, maintains the submitogenic level of IL-7 apparent under normal conditions.
The proliferation of CD4 + T cells transferred into Il7r
Rag1
À/À chimeras has been interpreted as support for a negative-feedback model of IL-7 homeostasis; namely, IL-7 production by Il7r À/À DCs is upregulated because of the lack of negative feedback from IL-7R signaling (Guimond et al., 2009 ). However, we showed above that IL-7 availability was increased in Il7r À/À hosts even in the absence of Il7 Figure 2 , host IV), indicating that IL-7 produced by Il7r
hematopoietic cells is insignificant in this model. Moreover, we found that the IL-7-driven proliferation of donor T cells in Il7r
À/À hosts occurred at the same rate even when DCs did not express IL-7, i.e., in Il7r Figure S3 , compare hosts VII and VIII). These findings suggest that BM-derived cells do not produce sufficient amounts of IL-7 to affect naive T cell homeostasis, regardless of their IL-7R expression status. Instead, IL-7R + BM-derived cells control IL-7 availability primarily through receptor-mediated consumption.
ILCs Compete for IL-7 within the T Cell Niche
Our data suggest that IL-7 is normally maintained at submitogenic levels by a cytokine sink composed of IL-7R + hematopoi- ILCs did not affect IL-7 production ( Figure 5B ). In addition to T cells, another IL-7-sensitive cell type was also found to expand in anti-CD90-treated Rag1 À/À mice: host pro-B cell numbers increased by $500% and $25% in the spleen and BM, respectively ( Figure 5C ). We next sought to determine whether the T cell niche would be disturbed by depletion of IL-7R + ILCs under normal non-lymphopenic conditions. However, a genetic approach to selectively manipulate ILCs in normal mice is not possible because ILCs and T cells share close similarities in gene expression (Bando and Colonna, 2016 (legend continued on next page) 2013) , we found that the increase in cell cycling was abrogated if ILC-depleted hosts were also treated with A7R34, indicating that signals from IL-7R are required for the observed response (Figure 5D ). To test the role of commensal microbiota, we examined the effect of ILC deletion in an acute version of this model by using germ-free Rag1 À/À mice. In these hosts, donor naive polyclonal T cells engaged in an increased rate of homeostatic proliferation after depletion of host ILCs ( Figures 5E and 5F ). Collectively, these results suggest that ILC depletion leads to an increased availability of IL-7 for T and B cells in a mechanism independent of commensal microbiota. Figure 4D ; Daussy et al., 2014; Klose et al., 2013; Luther et al., 2011; Vosshenrich et al., 2006) . IL-7R + NK1.1 + ILCs were conspicuously more prevalent in Rag1 À/À LNs than in B6 LNs, suggesting a population that could compete with T cells for IL-7 ( Figure 4B ). Figures 5G and 5H) . Moreover, the slight increase in SMARTA CD4 + T cell proliferation was abolished by A7R34 treatment, whereas an IL-7R-independent response remained for P14 CD8 + T cells. Because NK1.1 + cells are known to compete for IL-15, we surmised that IL-15 might drive the IL-7-independent proliferation of P14 CD8 + T cells observed in this model (Baccala et al., 2005; Do and Min, 2009; French et al., 2005; Purton et al., 2007) . Indeed, Il2rb À/À P14 CD8 + T cells, which cannot respond to IL-15, were more sensitive to A7R34 treatment and less responsive to NK1.1 and CD90.2 depletion than their wildtype counterparts ( Figure S6 ). These data support the notion that although CD90 + ILCs compete for IL-7, the NK1.1 + ILC subsets preferentially consume IL-15 over IL-7. Figure 6C ). Although longer incubations with IL-7 caused T cells to downregulate IL-7R to background levels, this was not the case for ILCs; moreover, IL-7R was upregulated much more rapidly on ILCs than on T cells after withdrawal of IL-7 ( Figure 6C ). It was difficult to compared the NK1. presumably as a result of the lack of IL-15 in the culture media ( Figure 6A ; data not shown). However, among IL-7R + ILCs, we observed similar IL-7R expression dynamics among all three groups of ILCs ( Figure 6D) Figure 6G ). ILCs cultured with IL-7 and after its withdrawal ( Figure 7A ). Analysis of mRNA expression of Gfi1, Foxp1, Gabpa, and Gabpb in T cells and ILCs, all factors reported to regulate Il7r transcription, did not reveal any difference in their pattern of modulation in the two cell populations (data not shown). One notable exception was Foxo1, which regulates Il7r expression (Kerdiles et al., 2009; Ouyang et al., 2009) . Whereas Foxo1 mRNA expression was rapidly downregulated in CD8 + T cells cultured with IL-7, a minimal downregulation occurred in ILCs ( Figure 7B ). Given that stimulation of T cells via the TCR or gc cytokine receptor results in FOXO1 phosphorylation and nuclear export (Hedrick et al., 2012) , sorted CD8 + T cells and ILCs were analyzed for phosphorylated FOXO1 (pFOXO1) before and after 6 hr of incubation with or without IL-7. Consistent with the finding that IL-7R expression is higher in ILCs than in T cells ( Figure 6A ), the relative amount of pFOXO1 (and the ratio of pFOXO1 to FOXO1) in freshly isolated CD8 + T cells was higher than that in fresh ILCs, and more importantly, the amount of pFOXO1 increased noticeably upon IL-7 encounter for CD8 + T cells, but not for ILCs ( Figures 7C and 7D ). Moreover, pAKT, which is known to phosphorylate FOXO1 (Hedrick et al., 2012) , was clearly detectable in CD8 + T cells, but not in ILCs cultured with IL-7 ( Figure 7C ). The failure by ILCs to readily downregulate FOXO1 expression upon IL-7 encounter appears to contribute to their ability to outcompete T cells for IL-7.
LN-Resident
Mechanism of Differential Modulation of IL-7Ra in T Cells and ILCs
DISCUSSION
The data presented herein demonstrate that IL-7 homeostasis for the T cell niche is regulated in a manner whereby the tasks of production and consumption of IL-7 are conducted by separate cellular compartments. We found that stromal sources of IL-7 were necessary and sufficient to drive homeostatic proliferation of naive T cells, confirming previous data for CD8 + T cells (Schluns et al., 2000) and extending the finding to include CD4 + T cells as well. Conversely, IL-7R + hematopoietic cells did not produce significant IL-7 themselves but were required for controlling levels of the cytokine in vivo. Although our findings are inconsistent with the argument that IL-7R maintains IL-7 homeostasis by mediating a negative-feedback loop on IL-7 production by hematopoietic cells, it is conceivable that such feedback occurs indirectly, e.g., via crosstalk between IL-7R + hematopoietic cells and the IL-7-producing stroma. Indeed, decreased IL-7 consumption by hematopoietic cells can be correlated with increased IL-7 transcripts in LN stroma (Miller et al., 2013) . However, the limited availability of IL-7 in lymphoreplete animals suggests that there would be no negative feedback on IL-7 production, and thus IL-7 homeostasis would necessarily be maintained through consumption during the steady state. A role for IL-7R on radioresistant cells in IL-7 homeostasis is suggested by our results indicating that naive donor T cells encountered slightly less IL-7 in Il7r
This observation is consistent with the finding that IL-7R + stromal cells restrict IL-7 availability in the T cell niche (Lundströ m et al., 2012) . Alternatively, the observation might also reflect the influence of a small number of IL-7R + hematopoietic cells in the Il7r À/À BM / Rag1 À/À chimeras that survived the process of irradiation and BM reconstitution. Pertinently, ILCs are noted for their resilience after lethal irradiation (Dudakov et al., 2012) , and our results indicate that ILCs restrict T cell access to IL-7. Thus, although we cannot exclude any potential contribution from IL-7R-expressing stromal cells, our data suggest that IL-7R + BM-derived cells occupy the primary role in regulating IL-7 levels. It is striking that so few ILCs have such a notable effect on IL-7 availability in the T cell and, ostensibly, pro-B cell niches. However, this is not the first instance where an outsized or even regulatory role has been ascribed to ILCs (Buonocore et al., 2010; Hepworth et al., 2013; Monticelli et al., 2011; Sonnenberg et al., 2012) . Furthermore, we report that ILCs are more resistant to IL-7R downregulation and can consume more IL-7 than T cells in vitro; such behavior could explain the significant impact of ILCs on IL-7 availability in vivo. Mechanistically, unlike T cells, ILCs appear to be resistant to IL-7-induced downregulation of FOXO1, which in turn regulates Il7r transcription (Kerdiles et al., 2009; Ouyang et al., 2009) , and this trait appears to be due to reduced signaling through the PI3K-AKT pathway. The were sorted and then incubated in culture media overnight or were treated with IL-7 (6 ng/ml) for the indicated periods (6 or 12 hr). For groups indicated as IL-17wo 3 hr, cells were incubated with IL-7 for 12 hr and then withdrawn from IL-7 culture and further incubated for 3 hr in media. Samples designated as ''fresh'' were processed immediately after sorting, and other samples were processed separately at the indicated time points. cDNAs from samples were prepared for real-time PCR with SYBR or TaqMan reduced efficiency of FOXO1 phosphorylation and inactivation in ILCs could reflect the absence in TCR signaling, another inducer of PI3K-AKT pathway in addition to gc cytokines. Although ILC3s are more competitive for IL-7 on a per-cell basis than the rest of the lymphocyte populations, in normal LNs, ILC3s are vastly outnumbered by T cells. Thus, although ILC3s can affect the homeostasis of T cells, the superior ability of ILC3s to consume IL-7 could be more important for prioritizing the survival of this small population within the T cell niche. This advantage could be important, for instance, during the contraction of an immune response (i.e., as an engorged T cell population begins to re-express IL-7R), because the increased competition for IL-7 would come at a point when ILC3s are crucial to the restoration of the LN architecture (Scandella et al., 2008) . One physiological situation where ILC consumption of IL-7 potentially impairs T cell survival is during the neonatal period. Despite the lymphopenic conditions during this period, it had been found that IL-7-driven homeostatic proliferation of T cells is inefficient in neonatal hosts (Min et al., 2003; Sch€ uler et al., 2004) . The reason behind this was recently suggested to be due to the presence of ILCs, which are over-represented during the neonatal period but rapidly decline with age (Kelly and Scollay, 1992; Sawa et al., 2010) . Hence, it was recently shown that depletion of CD90 + cells led to a dramatic increase in the rate of IL-7-driven proliferation of naive T cells in Rag1 À/À neonatal hosts (Bank et al., 2016) . Although similar findings were reported in B6 neonatal hosts (Bank et al., 2016) , this result is difficult to interpret because the anti-CD90 mAb treatment would have depleted emerging host T cells in addition to ILCs.
Collectively, these data provide direct experimental evidence for the long-standing hypothesis that IL-7, which is constitutively produced by radioresistant cells, is maintained in limited supply through consumption by IL-7R + hematopoietic cells (Fry and Mackall, 2005; Mazzucchelli and Durum, 2007) . The adoptive-T-cell-transfer approach utilized here to detect IL-7 in vivo circumvents the technical issues with insensitive histological reagents and enigmatic transcriptional regulation to reveal the IL-7 that is actually available within the T cell niche. The significance of the system wherein ILCs and T cells have evolved to share IL-7 resources remains to be determined. Advances in our understanding of this intra-specific competition will come with models that allow temporally controlled conditional deletion of Il7r from a select group of ILCs without affecting most T cells.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: of T cells as previously described (Martin et al., 2013) . BM-reconstituted animals were rested for at least 4 weeks prior to experiments. CD90-disparate Rag1 À/À chimeric mice were prepared by i.v. transfer of 2.5 3 10 7 to 5 3 10 7 whole lymphocytes or purified CD4 + and CD8 + T cells (enriched by negative selection with magnetic beads as described in Martin et al., 2013) from the LN of CD90.1 + mice into CD90.2 + Rag1 À/À hosts. T cells were enriched by negative selection with magnetic beads as described (Martin et al., 2013) : in brief, single-cell suspensions of LN and spleen were labeled with biotinylated antibodies against B220, CD11c, CD11b, CD19, and CD24 and subsequently IMag Streptavidin Particles Plus-DM according to manufacturer's instructions (BD Biosciences). CD90-disparate Rag1 À/À chimeric mice were allowed to rest for 8-10 weeks prior to experiments as described (Sonnenberg et al., 2012) . Experiments involving the use of animals were approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute, or of The La Jolla Institute for Allergy and Immunology, or of the POSTECH Biotech Center.
METHOD DETAILS
Reagents for Flow Cytometry Antibodies were purchased from Biolegend (San Diego, CA), Tonbo (San Diego, CA), eBioscience (San Diego, CA), or BD Biosciences and consisted of the following clones: CD4 (RM4-5), CD8 (53-6.7), Va2 (B20.1), CD90.1 (OX-7 or HIS51), IL-7Ra (A7R34), CD45.1 (A20), CD45.2 (104), CD3 (145-2C11), CD90.2 (53-2.1 or 30H12), GATA-3 (L50-823), RORgt (B2D), NK1.1 (PK136), T-bet (4B10), eomesodermin (Dan11mag), Ki67 (SolA15), CD44 (IM7), CD19 (1D3), CD122 (5H4 or TM-b1), MHC-II (M5/114.15.2), CD11c (N418), and B220 (RA3-6B2). Intracellular staining for Ki67, Tbet, eomesodermin, GATA-3, and RORgt was conducted using the Foxp3 / Transcription Factor Staining Buffer Set (eBioscience) and live/dead discrimination was achieved with Zombie Aqua Fixable Viability Kit (Biolegend).
Antibody Treatments of Mice
The hybridoma for anti-IL-7R mAb clone A7R34 was a gift of P. Marrack (National Jewish Health and U. of Colorado, Denver, CO) and was produced as ascites fluid and purified by affinity chromatography at The Scripps Research Institute Antibody Core Facility or purchased from Bio X Cell (West Lebanon, NH). A7R34 from either source performed equally our hands. Anti-Thy1.2, clone 30H-12, and isotype control (LTF-2), anti-NK1.1 (PK136) and anti-CD90.2 (19E12) were purchased from Bio X Cell (West Lebanon, NH 
Cellular Proliferation
Donor lymphocytes were prepared from the pooled (inguinal, axillary, cervical. and mesenteric) LN of donor mice and either labeled directly or purified to specific T cell subsets (where specified) and then labeled in 5 mM of either CFSE (5-[and 6-] carboxyfluorescein diacetate, succinimidyl ester) or CTV (CellTrace Violet, Molecular Probes) as previously described (Martin et al., 2013) . In brief, cells were washed in cold PBS with 0.1% bovine serum albumin, pelleted at 200 3 g for 10 min at 8 C and resuspended at 10 7 /mL in prewarmed (37 C) PBS/BSA. Proliferation dye (either CFSE or CTV) was added directly to cells in warmed PBS/BSA (1 mL of 5mM dye per 1mL of cells in PBS/BSA) and mixture was immediately mixed by vortex and incubated at 37 C for 10 min. Labeling reaction was terminated and washed by adding at least one volume of 4 C DMEM with 0.5% FCS and pelleted as above. Labeled cells were resuspended in DMEM/FCS and transferred to host mice i.v. on d0, and donor cell proliferation was analyzed on d5 (CD8 + TCR transgenic donors) or d7-8 (polyclonal and CD4 + TCR transgenic donors). Division index scores were calculated using the algorithm included within the FlowJo software package (Tree Star). When one or more samples in an experiment contained no cells remaining in the undivided (generation 0) and the FlowJo software failed to call appropriate generation numbers, the division indices for all samples in that experiment were calculated manually according to the following equation (the same used by FlowJo), adopted from Roederer (2011):
where i is the generation number and N i is the number of cells in the generation i.
Gene Expression Analysis by Quantitative PCR For measurement of Il7 transcripts in LN, RNA was prepared from whole inguinal LN using the RNeasy Micro Kit (QIAGEN) and cDNA was generated with the SuperScript III First Strand Synthesis System using oligo(dT) primers (Life Technologies). Quantitative PCR was conducted using the Power SYBR Green PCR Master Mix (Applied Biosystems) with primers for Il7: 5 0 -CTG ATG ATC AGC ATC GAT GAA TTG G-3 0 and 5 0 -GCA GCA CGA TTT AGA AAA GCA GCT T-3 0 or for Hprt: 5 0 -GTT GGA TAT GCC CTT GAC-3 0 and 5 0 -AGG ACT AGA ACA CCT GCT-3 0 . Raw Cp values were exported from the LightCycler 480 (Roche) and the relative quantifications (with efficiency correction) were calculated according to method of Pfaffl (Pfaffl, 2001 ). For analysis of gene expression in freshly sorted cells or sorted cells cultured with or without 6ng/ml IL-7, recombinant human IL-7 (rhIL-7) was obtained from NCI Biological Resources Branch and total RNA was isolated using the RNeasy Micro Kit (QIAGEN). cDNA was synthesized using QuantiTect Reverse Transcription Kit (QIAGEN). RT-PCR was then performed using Power SYBR Green PCR master kit (Applied Biosystems) for the following genes, IL-7Ra (Fwd, 5 0 -CAC ACA AGA ACA ACA ATC CCA CA-3 0 ; Rev, 5 0 -GAT CCC ATC CTC CTT GAT TCT TG-3 0 ), Foxp1 (Fwd, 5 0 -CCC CGT GAA GCT GAT GGT-3 0 ; Rev, 5 0 -ATG GCA GAT AGG GCA GGT AAA C-3 0 ), GABPa (Fwd, 5 0 -GTA CCA GAT TAT TAT GCA AGA CC-3 0 ; Rev, 5 0 -TAA AGA AGA TCG CCT ACT GAG C-3 0 ), GABPb (Fwd, 5 0 -AGA CCA ACA AAG AAG CCG-3 0 ; Rev, 5 0 -TTA AGT CCC GTT ATC AAG CTG TAG-3 0 ) and Gfi1 (Fwd, 5 0 -GGA CAA GAG CGT GGG CG-3 0 ; Rev 5 0 -GTG CAC CTC CAG CCC GT-3 0 ). Primer/probe set for Foxo1 was obtained as TaqMan Gene expression Assays from Applied Biosystems and RT-PCR was performed using TaqMan Universal PCR Master Mix (Applied Biosystems). mRNA levels of each gene were normalized to those of Hprt1 and relative gene expression among samples were then determined.
In Vitro IL-7R Expression Analysis Single cell suspensions were prepared from B6 or Rag1 À/À LN and cultured at 2 3 10 5 to 5 3 10 5 /mL in media (RPMI with 10% FCS, 10 mM HEPES, 2 mM L-glutamine, 100 u/mL penicillin, and 100 mg/mL streptomycin) and incubated at 37 C with 5% CO 2 . The media for samples cultured with IL-7 was supplemented with 6 ng/mL rhIL-7. Since the total culture time was equal for all samples in the same experiment (t < 24 hr), those samples that were cultured with or without IL-7 for any time t 1 (where t 1 < t) were cultured in the reciprocal condition for the proceeding or remaining time t 2 (t = t 1 + t 2 ). Samples that were switched between IL-7 culture conditions during the experiment were washed 23 with media alone before being returned to culture in fresh media of the reciprocal condition. In parallel, samples that were cultured in the same IL-7 culture condition for the entire experiment were removed once during the culture period, washed 23 with media alone and then returned to culture in fresh media of the same condition. At the end of the experiment, all samples were stained and analyzed for their expression of IL-7R and the indicated markers by flow cytometry. To compare IL-7R expression kinetics between cell types with disparate levels of IL-7R expression, the values for geometric MFI (gMFI) of surface IL-7R staining were visualized as a function of the observed range of fluorescence for each cell type (% normalized MFI). The % normalized MFI was calculated for each subset by first subtracting the background fluorescence of that subset (i.e., the IL-7R gMFI of that cell subset in a parallel sample that had been stained with a fluorescence-minus-one control for the IL-7R detecting reagent) and then these values were expressed as a percent of the value for the same cell subset from the sample that was incubated without IL-7 for the full culture period (i.e., 0 hr in culture with IL-7).
In Vitro IL-7 Consumption ILC or CD44 lo T cells were sorted from Rag1 À/À , B6, or RORgt-GPF mice and incubated at 37 C and 5% CO 2 in complete media supplemented with 200 pg/mL rhIL-7. After 2 days, 1 culture supernatants were harvested and the remaining concentration of IL-7 was determined in 2 cultures by in vitro T cell survival assay: a 2 culture was prepared with 5 3 10 5 /mL freshly harvested B6 LN cells in a 1:1 mixture of 1 culture supernatant and either fresh media alone or, as a control, media supplemented with 200 pg/mL rhIL-7. In parallel, 5 3 10 5 /mL B6 LN were cultured cells in fresh media with serial dilutions of 0.1-200 pg/mL IL-7 so as to establish a standard curve. 48 hr later, cells were washed and stained in 2 ng/mL propidium iodide (PI), the anti-FcgRII/ FcgRIII mAb (clone 2.4G2), and fluorescently labeled antibodies against CD4 and CD8. The frequency of surviving (PI À ) CD8 + CD4
À T cells was determined by flow cytometry and the concentration of IL-7 in the 2 culture media was calculated from the standard curve.
Immunoblot Analysis Naive CD8 + T cells from B6 mice and ILCs from Rag1 À/À mice were sorted and incubate in culture media with or without IL-7 (6 ng/ml) for 6 hr. 5 3 10 5 cells were processed for immunoblotting as described previously (Cho et al., 2013) . In brief, cells washed once in icecold PBS were then lysed for 15-30 min on ice in 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium purophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 1 mM PMSF, and 1 mg/mL aprotinin and leupeptin. Total lysates were boiled in sample buffer with reducing agent [Invitrogen Nupage LDS sample buffer (43): Cat# NP0007, and sample reducing buffer (103): Cat# NP0004] and run on 4%-12% Bis-Tris SDS-PAGE Gels (Invitrogen), transferred onto nitrocellulose membranes (Invitrogen), blocked with 5% dry nonfat milk in TBS (pH 7.4) containing 0.1% Tween-20. The following antibodies were used for probing: pAKT(Ser473) (193H12), FOXO1 (C29H4) and Phospho-FOXO1 (Thr24)/FOXO3a (Thr32) (Cell Signaling Technology, Beverly, MA) and b-actin (AC-15 ascites fluid) (Sigma-Aldrich, St Louis, MO). Blots were first probed for phospho-FOXO1 and then stripped with Restore Western Blot Stripping buffer (Invitrogen) prior to probing for total FOXO1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical significance was assessed by unpaired two-tailed t test (for pairwise comparison) or a one-way ANOVA (for group comparisons) with a Tukey or Bonferroni post-test depending on sample sizes. Statistical calculations were performed using Prism 5 (GraphPad) and a p value < 0.05 was considered statistically significant.
